Search research articles
Contact Us
Filters
Showing results (311-320 of 323) with videos related to
Page
of 33
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 2, 2021
Response to Rucaparib in BRCA-Mutant Metastatic Castration-Resistant Prostate Cancer Identified by Genomic Testing in the TRITON2 Study
Andrea Loehr, Akash Patnaik, David Campbell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 16, 2020
Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a <i>BRCA1</i> or <i>BRCA2</i> Gene Alteration
Wassim Abida, Akash Patnaik, David Campbell, et al.
European Urology Oncology
|
December 31, 2025
Corrigendum to "Treatment Trajectories in Metastatic Hormone-sensitive Prostate Cancer: A PIONEER+ Big Data Analysis" [Eur. Urol. Oncol. 8(5) (2025) 1340-1349]
Rossella Nicoletti, Alex Qinyang Liu, Susan Evans-Axelsson, et al.
European Urology Oncology
|
August 21, 2023
Real-world Outcomes and Predictive Biomarkers for <sup>177</sup>Lutetium Prostate-specific Membrane Antigen Ligand Treatment in Metastatic Castration-resistant Prostate Cancer: A European Association of Urology Young Academic Urologists Prostate Cancer Working Group Multi-institutional Observational Study
Mona Kafka, Andreas Horninger, Gianpaolo di Santo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 23, 2020
Non-BRCA DNA Damage Repair Gene Alterations and Response to the PARP Inhibitor Rucaparib in Metastatic Castration-Resistant Prostate Cancer: Analysis From the Phase II TRITON2 Study
Wassim Abida, David Campbell, Akash Patnaik, et al.
European Urology Oncology
|
October 8, 2025
Treatment Trajectories in Metastatic Hormone-sensitive Prostate Cancer: A PIONEER+ Big Data Analysis
Rossella Nicoletti, Alex Qinyang Liu, Susan Evans-Axelsson, et al.
European Urology Oncology
|
September 11, 2024
Liquid Biopsy in Progressing Prostate Cancer Patients Starting Docetaxel with or Without Enzalutamide: A Biomarker Study of the PRESIDE Phase 3b Trial
Maria Ruiz-Vico, Daniel Wetterskog, Francesco Orlando, et al.
JCO Precision Oncology
|
September 14, 2020
Plasma Androgen Receptor Copy Number Status at Emergence of Metastatic Castration-Resistant Prostate Cancer: A Pooled Multicohort Analysis
Anuradha Jayaram, Anna Wingate, Daniel Wetterskog, et al.
European Urology
|
November 5, 2025
Comparative Survival in Metastatic Hormone-sensitive Prostate Cancer by Volume of Disease and Timing of Metastasis: A Living Network Meta-analysis
Irbaz Bin Riaz, Syed Arsalan Ahmed Naqvi, Kunwer Sufyan Faisal, et al.
European Urology
|
June 5, 2023
Rucaparib for the Treatment of Metastatic Castration-resistant Prostate Cancer Associated with a DNA Damage Repair Gene Alteration: Final Results from the Phase 2 TRITON2 Study
Wassim Abida, David Campbell, Akash Patnaik, et al.
Page
of 33
Search research articles
Search
Showing results (311-320 of 323) with videos related to
Sort By:
Page
of 33
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 2, 2021
Response to Rucaparib in BRCA-Mutant Metastatic Castration-Resistant Prostate Cancer Identified by Genomic Testing in the TRITON2 Study
Andrea Loehr, Akash Patnaik, David Campbell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 16, 2020
Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a <i>BRCA1</i> or <i>BRCA2</i> Gene Alteration
Wassim Abida, Akash Patnaik, David Campbell, et al.
European Urology Oncology
|
December 31, 2025
Corrigendum to "Treatment Trajectories in Metastatic Hormone-sensitive Prostate Cancer: A PIONEER+ Big Data Analysis" [Eur. Urol. Oncol. 8(5) (2025) 1340-1349]
Rossella Nicoletti, Alex Qinyang Liu, Susan Evans-Axelsson, et al.
European Urology Oncology
|
August 21, 2023
Real-world Outcomes and Predictive Biomarkers for <sup>177</sup>Lutetium Prostate-specific Membrane Antigen Ligand Treatment in Metastatic Castration-resistant Prostate Cancer: A European Association of Urology Young Academic Urologists Prostate Cancer Working Group Multi-institutional Observational Study
Mona Kafka, Andreas Horninger, Gianpaolo di Santo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 23, 2020
Non-BRCA DNA Damage Repair Gene Alterations and Response to the PARP Inhibitor Rucaparib in Metastatic Castration-Resistant Prostate Cancer: Analysis From the Phase II TRITON2 Study
Wassim Abida, David Campbell, Akash Patnaik, et al.
European Urology Oncology
|
October 8, 2025
Treatment Trajectories in Metastatic Hormone-sensitive Prostate Cancer: A PIONEER+ Big Data Analysis
Rossella Nicoletti, Alex Qinyang Liu, Susan Evans-Axelsson, et al.
European Urology Oncology
|
September 11, 2024
Liquid Biopsy in Progressing Prostate Cancer Patients Starting Docetaxel with or Without Enzalutamide: A Biomarker Study of the PRESIDE Phase 3b Trial
Maria Ruiz-Vico, Daniel Wetterskog, Francesco Orlando, et al.
JCO Precision Oncology
|
September 14, 2020
Plasma Androgen Receptor Copy Number Status at Emergence of Metastatic Castration-Resistant Prostate Cancer: A Pooled Multicohort Analysis
Anuradha Jayaram, Anna Wingate, Daniel Wetterskog, et al.
European Urology
|
November 5, 2025
Comparative Survival in Metastatic Hormone-sensitive Prostate Cancer by Volume of Disease and Timing of Metastasis: A Living Network Meta-analysis
Irbaz Bin Riaz, Syed Arsalan Ahmed Naqvi, Kunwer Sufyan Faisal, et al.
European Urology
|
June 5, 2023
Rucaparib for the Treatment of Metastatic Castration-resistant Prostate Cancer Associated with a DNA Damage Repair Gene Alteration: Final Results from the Phase 2 TRITON2 Study
Wassim Abida, David Campbell, Akash Patnaik, et al.
Page
of 33